Clinical Trial: Performance of CCoat Intra-Articular Injections in Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Double-Blind, Multi-center Trial

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07052851) titled 'Performance of CCoat Intra-Articular Injections in Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Double-Blind, Multi-center Trial' on June 29.

Brief Summary: Performance of CCoat Intra-Articular Injections in Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Double-Blind, Multi-center Trial

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Osteoarthritis, Knee

Intervention: DEVICE: CCoat, Liposphere Ltd

a single IA injection of 4 ml CCoat

DEVICE: Synvisc-One(R) (hylan G-F 20)

Group 2 (Active Comparator): a single IA Synvisc-One(R) (hylan G-F 20) of 6 mL, Genzyme Corporation...